DrugPatentWatch Database Preview
Glenmark Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has ninety-three approved drugs.
There are eight tentative approvals on GLENMARK PHARMS drugs.
Summary for Glenmark Pharms
| US Patents: | 0 |
| Tradenames: | 75 |
| Ingredients: | 71 |
| NDAs: | 93 |
Drugs and US Patents for Glenmark Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms | MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 090480-001 | Jun 8, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Glenmark Pharms Ltd | PIMECROLIMUS | pimecrolimus | CREAM;TOPICAL | 211769-001 | Aug 29, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Glenmark Pharms | AZELAIC ACID | azelaic acid | GEL;TOPICAL | 204637-001 | Nov 19, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
